A large regional commercial health plan with over 1.5 million lives and more than $3 billion in PBM spend had transitioned to one of the industry’s leading PBMs but was not realizing the value they had anticipated. Despite managing clinical policies and prior authorization processes in-house, the organization lacked the transparency, cost control, and operational flexibility required to effectively meet the evolving needs of their diverse client base.
